Skip to main content

Table 4 Association between mildly reduced eGFR and obese phenotype in different gender

From: Metabolic healthy obesity is associated with higher incidence of mild decrease estimate glomerular rate in rural northeast Chinese

 

Model 1

Model 2

Model 3

P-value

OR (95%CI)

P-value

OR (95%CI)

P-value

OR (95%CI)

Total

 MHNO

1.00(reference)

 

1.00(reference)

 

1.00(reference)

 

 MHO

1.35 (1.11,1.64)

0.002

1.63 (1.33,1.99)

< 0.001

1.62 (1.32,1.98)

< 0.001

 MANO

1.11 (0.84,1.46)

0.453

0.89 (0.67,1.19)

0.438

0.87 (0.65,1.17)

0.280

 MAO

1.43 (1.19,1.71)

< 0.001

1.48 (1.22,1.78)

< 0.001

1.44 (1.17,1.75)

< 0.001

Women

 MHNO

1.00(reference)

 

1.00(reference)

 

1.00(reference)

 

 MHO

1.36 (1.01,1.83)

0.045

1.65 (1.20,2.27)

0.002

1.63 (1.18,2.25)

0.003

 MANO

1.48 (1.05,2.09)

0.026

0.98 (0.67,1.41)

0.920

0.97 (0.66,1.41)

0.860

 MAO

1.43 (1.10,1.87)

0.008

1.17 (0.88,1.55)

0.309

1.18 (0.87,1.59)

0.290

Men

 MHNO

1.00 (reference)

 

1.00 (reference)

 

1.00 (reference)

 

 MHO

1.35 (1.05,1.74)

0.021

1.59 (1.22,2.07)

0.001

1.62 (1.24,2.11)

0.001

 MANO

0.67 (0.41,1.09)

0.106

0.61 (0.37,1.01)

0.053

0.61 (0.37,1.01)

0.055

 MAO

1.45 (1.13,1.86)

0.003

1.72 (1.33,2.23)

< 0.001

1.74 (1.32,2.29)

< 0.001

  1. Model 1. Unadjusted; Model 2. Adjusted for age, current smoking, current drinking (in addition to gender in total group); Model 3. Adjusted for age, current smoking, current drinking, chronic diseases, LDL-C ALT, AST (in addition to gender in total group), MHNO metabolically health non-obese, MHO metabolically healthy obese, MANO metabolically abnormal obese, MAO metabolically abnormal obese